Arformoterol Tartrate Solution
Product Images NDC 72603-208

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 72603-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 01)

Chemical structure diagram of arformoterol tartrate showing the molecular arrangement of its components in the active ingredient.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 02)

A line graph showing the mean change in FEV1 (liters) over 12 hours postdose for Clinical Trial A at Week 0 (Day 1). The graph compares placebo and 15 mcg arformoterol tartrate inhalation solution BID, illustrating greater improvement in FEV1 with arformoterol over time.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 03)

A line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 12' depicting mean change from baseline FEV1 (L) on the vertical axis and hours postdose on the horizontal axis. It compares placebo (blue line, decreasing near zero) and 15 mcg arformoterol tartrate inhalation solution BID (pink line, showing an initial increase peaking around 0.25 L followed by gradual decline over 12 hours). A legend identifies the placebo group and the arformoterol tartrate 15 mcg BID group with baseline FEV1 values and sample sizes.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 04)

An instructional illustration showing a person's hand twisting or removing a cap from a small vial, likely demonstrating how to open a respiratory solution vial for use.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 05)

An instructional black-and-white line drawing showing a hand holding a small inhalation device poised above a labeled reservoir component. The illustration depicts the positioning for administering the respiratory solution dose from the device into the reservoir, relevant for arformoterol tartrate inhalation solution use.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 06)

An instructional illustration showing two figures: Figure 3 depicts a mouthpiece attachment for a respiratory inhalation device, and Figure 4 shows a face mask attachment for the same type of device. Both are components related to the administration of inhalation medication.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 07)

An illustration showing a compressor unit with a labeled control knob and display, and a connected tubing labeled 'TUBING'. This diagram likely depicts part of a respiratory inhalation setup for administering medication.*

FDA Label Image

Image (48937761 7d65 4ac1 B884 Bfb73099da73 08)

An illustration showing a person using a respiratory inhalation device, demonstrating the correct positioning of the mouth around the inhaler mouthpiece. The image appears instructional for proper inhaler use.*

FDA Label Image

Pouch 1 Unit (48937761 7d65 4ac1 B884 Bfb73099da73 09)

Label for arformoterol tartrate inhalation solution, 15 mcg per 2 mL, a respiratory inhalation solution from NorthStar Rx LLC. The label includes dosing and storage information, an NDC number 72603-208-01, and instructions for use with a 2 mL sterile unit-dose vial. It also notes the product is Rx only and to keep out of reach of children.*

FDA Label Image

5s Foil (48937761 7d65 4ac1 B884 Bfb73099da73 10)

Label for arformoterol tartrate inhalation solution, 15 mcg per 2 mL. The product is supplied as sterile unit-dose vials, four 2 mL vials per package. The label includes storage instructions, manufacturer NorthStar Rx, and advises unused vials should be returned to the pouch after opening. It is designated for respiratory inhalation use and is prescription only.*

FDA Label Image

30 Carton (48937761 7d65 4ac1 B884 Bfb73099da73 11)

Arformoterol tartrate inhalation solution 15 mcg per 2 mL sterile unit-dose vial carton label. The label indicates the product is for oral inhalation only, with a package size of 30 unit-dose vials. Manufactured by NorthStar Rx LLC and mentions storage instructions to keep refrigerated or store at room temperature for up to 6 weeks. The label includes NDC 72603-208-30 and states Rx only.*

FDA Label Image

60 (48937761 7d65 4ac1 B884 Bfb73099da73 12)

Box packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg per 2 mL, presented as sterile unit dose vials. The label shows 60 x 2 mL sterile unit dose vials (15 x 4 unit dose vials per pouch). Manufactured by NorthStar Rx LLC and Mankind Pharma Limited, India. Storage instructions include refrigeration or room temperature up to 6 weeks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.